Overview of various techniques/platforms with critical evaluation of each

Current Treatment Options in Oncology

Volumn 14, Issue 4, 2013, Pages 623-633

  Agwa, Eberechi ^a   Ma, Patrick C ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Cancer of unknown primary; Metastases; Molecular profiling; Tissue of origin

Indexed keywords

MESSENGER RNA;

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; CHROMOSOME TRANSLOCATION; COPY NUMBER VARIATION; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL DEVICE; METASTASIS; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; NEXT GENERATION SEQUENCING; PREDICTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA SPLICING; SEQUENCE ANALYSIS; TISSUE CHARACTERIZATION;

DIAGNOSTIC IMAGING; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NEOPLASMS, UNKNOWN PRIMARY; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS;

EID: 84890788578     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-013-0259-z     Document Type: Review

References (28)

1. Greco FA, Hainsworth JD. Cancer of unknown primary site. In: Devita Jr VT, Hellman S, Rosenberg S, editors. Cancer: principles and practice of oncology. 8th ed. Philadelphia: Lippincott; 2008. p. 2363-87.
2. Greco FA, Oien K, Erlander M, Osborne R, Varadhachary G, et al. Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. Ann Oncol. 2012;23:298-304. Excellent review on CUP and Current diagnostic approach.
3. Tong KB MK, Hubert HB, et al. (2006) Incidence, costs of care and survival of Medicare beneficiaries diagnosed with carcinoma of unknown primary (CUP). In poster presented at Annual Meeting of Association of Molecular Pathology, November 17.
4. Li X, Quigg RJ, Zhou J, Gu W, Nagesh Rao P, et al. Clinical utility of microarrays: current status, existing challenges and future outlook. Curr Genomics. 2008;9:466-74.
5. Sotiriou C, Piccart MJ. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer. 2007;7:545-53.
6. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A. 2001;98:15149-54.
7. Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 2001;61:7388-93.
8. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462-9.
9. Ma XJ, Patel R, Wang X, Salunga R, Murage J, et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006;130:465-73.
10. Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, et al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res. 2005;65:4031-40.
11. Talantov D, Baden J, Jatkoe T, Hahn K, Yu J, et al. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. J Mol Diagn. 2006;8:320-9.
12. Monzon FA, Lyons-Weiler M, Buturovic LJ, Rigl CT, Henner WD, et al. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin. J Clin Oncol. 2009;27:2503-8. Largest Validation study to date for a gene expression based test for tissue of origin determination.
13. Greco FA, Spigel DR, Yardley DA, Erlander MG, Ma XJ, et al. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction. Oncologist. 2010;15:500-6.
14. Greco FA, Pavlidis N. Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors. Semin Oncol. 2009;36:65-74.
15. Dumur CI, Fuller CE, Blevins TL, Schaum JC, Wilkinson DS, et al. Clinical verification of the performance of the pathwork tissue of origin test: utility and limitations. Am J Clin Pathol. 2011;136:924-33. Explains not just the clinical usefulness of the test but the limitations as well.
16. Dumur CI, Lyons-Weiler M, Sciulli C, Garrett CT, Schrijver I, et al. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers. J Mol Diagn. 2008;10:67-77.
17. Monzon FA, Dumur CI. Diagnosis of uncertain primary tumors with the Pathwork tissue-of-origin test. Expert Rev Mol Diagn. 2010;10:17-25. Good expert review on pathwork Tissue of Origin Test.
18. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol. 2000;24:1016-9.
19. Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res. 1999;27:4436-43.
20. Pillai R, Deeter R, Rigl CT, Nystrom JS, Miller MH, et al. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens. J Mol Diagn. 2011;13:48-56.
21. Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist. 2012;17:801-12. Expands on the initial microRNA based assay from 25 to 42 tumor types.
22. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257-61.
23. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673-7.
24. Rosenwald S, Gilad S, Benjamin S, Lebanony D, Dromi N, et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod Pathol. 2010;23:814-23.
25. Klopfleisch R, Weiss AT, Gruber AD. Excavation of a buried treasure-DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol Histopathol. 2011;26:797-810.
26. Erlander MG, Ma XJ, Kesty NC, Bao L, Salunga R, et al. Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. J Mol Diagn. 2011;13:493-503.
27. Krishna M. Diagnosis of metastatic neoplasms: an immunohistochemical approach. Arch Pathol Lab Med. 2010;134:207-15.
28. Garraway LA. Genomics-driven oncology: framework for an emerging paradigm. J Clin Oncol. 2013;31:1806-14.